Home About the Conference Memorandum Presentations Listen to the conference Organisers&Sponsors Contact function startGallery() { var myGallery = new ...
DEFEND is a Phase 3 clinical study evaluating a new investigational agent called otelixizumab. In type 1 diabetes, beta cellsthe cells that make insulinare d ...
Home About #rt-img{background:url(http://b-school.co.in/wp-content/themes/aapna/album/pic4.jpg) no-repeat right;} The Biography of a Manager - The Coach As an ...